Health
In the 2022/2023 business year, the company’s product portfolio consisted of 653 products

To Lead a Long and Healthy Life
Health means more than just the lack of illnesses. More

The continuous operation of Egis is vital

The quality of life of millions depends on the availability of our medicines, as Egis sells the most boxes of medicine in Hungary. Hungarian doctors most often choose Egis medicines particularly for the therapy of cardiovascular diseases, which is a common disease. Our medicines provide therapeutic solutions for the diseases cardiovascular diseases (38%), for the illnesses of the central nervous system (17%) and respiratory system (10%), further 10% are cancer treatment and immunotherapeutic drugs. Taking these medicines continuously is essential for maintaining the patients’ quality of life and for the success of the therapy. More

Egis Strengthens European Presence in the Biosimilar Area

Hungarian-based Egis Pharmaceuticals PLC signed an exclusive distribution agreement with Mundipharma network for a pegfilgrastim biosimilar. Pursuant to the agreement, Egis gains the exclusive distribution rights related to the medicine used to reduce a common side effect of cancer treatment called neutropenia and the related life-threatening infections. Thus, Egis gets the opportunity to launch this pegfilgrastim biosimilar product in four Eastern European countries. More

Egis Attends Heart Day

Egis attended the event with a fork lift truck simulator that playfully presented the firm’s therapeutic areas.

More

Over 1000 participants at the national PAD Day

The screening tests conducted in Budapest and at five rural venues - Debrecen, Győr, Miskolc, Pécs and Szeged - and combined with free medical consulting attracted more than 1000 visitors.

More

Over 2 million vitamin capsules for families in need

Egis has donated 50,000 boxes of vitamin C capsules to Hungarian families coping with difficulties. The donations were taken by the Children’s Food Foundation to residents in underdeveloped regions under the “Pharmacy for the Poor” programme.

More
Other channels
Egis World
Egis' products are sold to 100 countries.
Our People
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
Innovation
In the 2022/2023 business year, we spent EUR 48 million on research and development
Corporate Social Responsibility
Healthcare and sharing knowledge are in the heart of our CSR activities
Events
Our highlighted past and future events you shouldn't miss
Quick news

Part of Gyógyszergyári Street Renamed after István Orbán

Jan. 31.
More

Three Egis Subsidiaries Among the Best Employers

Jun. 14.
More

Egis strengthens European presence in the biosimilar area

Jun. 13.
More

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox